Anti-RBD IgG antibodies and neutralizing antibody levels after the second BNT162b2 dose in patients with plasma cell disorders

Patients with plasma cell disorders (PCD) are at an increased risk for severe morbidity and mortality due to COVID-19. Recent data have suggested that patients with hematological malignancies, including those with PCD, have suboptimal antibody response to COVID-19 vaccination. We compared the antibo...

Descripción completa

Detalles Bibliográficos
Autores principales: Magen, Hila, Avigdor, Abraham, Nevo, Lee, Fried, Shalev, Gibori, Amit, Levin, Einav G., Lustig, Yaniv, Shkury, Eden, Rahav, Galia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10150979/
https://www.ncbi.nlm.nih.gov/pubmed/37126496
http://dx.doi.org/10.1371/journal.pone.0284925

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10150979/
https://www.ncbi.nlm.nih.gov/pubmed/37126496
http://dx.doi.org/10.1371/journal.pone.0284925

Ejemplares similares